Mahoney Stephen F. 4
4 · Kiniksa Pharmaceuticals, Ltd. · Filed Sep 24, 2018
Insider Transaction Report
Form 4
Mahoney Stephen F.
President & COO10% Owner
Transactions
- Award
Share Option
2018-09-20+50,000→ 50,000 totalExercise: $30.93Exp: 2028-09-19→ Class A Common Shares (50,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three-year period thereafter. The vesting commencement date is September 20, 2018.